WHO stops testing of hydroxychloroquine in COVID-19 patients



Geneva / London, June 17  A large multi-national trial of treating COVID-19 patients with malaria drug hydroxychloroquine's trial halted the results of other tests, the World Health Organization said on Wednesday. Happened.

"The hydroxychloroquine arm of the Solidarity Trial has been discontinued," WHO expert Ana Maria Henao-Restrepo said at a news conference.

Post a Comment

0 Comments